MenQuadfi is indicated for active immunisation of individuals from the age of 12 months and older, against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y.

MedNytt - Metodevarsling for helsetjenesten
(/mednytt/legemidler/menquadfi-is-indicated-for-active-immunisation-of-individuals-from-the-age-of-12-months-and-older-against-invasive-meningococcal-disease-caused-by-neisseria-meningitidis-serogroups-a-c-w-and-y)